Palantir remains a buy as recent software stock sell-offs create an attractive entry amid robust Q4 results and accelerating fundamentals. PLTR delivered 70% y/y revenue growth to $1.41B, outpacing expectations, with commercial revenue up 82% and U.S. commercial accelerating to 137% y/y. Backlog surged 143% y/y to $4.21B, billings climbed 91%, and net retention reached 139%, underscoring strong demand and sticky customer relationships.

Expands Colliers' global engineering reach, expertise, and growth opportunities Expands Colliers' global engineering reach, expertise, and growth opportunities

HANGZHOU, China, Feb. 3, 2026 /PRNewswire/ -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) (the "Company") today announced that its strategic cooperation with Xinhui Solar Technology Group Co., Ltd. has further deepened.

BEIJING, Feb. 3, 2026 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) ("Autozi" or the "Company") today announced that it has further deepened its cooperation with Velocar Ltd.

Woodward delivered a standout Q1 2026, with 29% sales growth and EPS up 61%, far surpassing consensus estimates. WWD raised full-year guidance, now expecting 14-18% sales growth and EPS of $8.20-8.60, reflecting robust commercial aftermarket and industrial momentum. Updated price targets imply 14% upside to $371.87 for 2027 and 28% upside to $419.09 for 2028, underpinned by double-digit sales and EBITDA growth.

– First medical device company to receive excellence recognition in accordance with ISO 23592 – Gold Stevie® Award for Customer Service Success – Bronze Stevie® Award for AI & Tech Focused Digital Transformation Team of the Year SAN DIEGO, Feb. 3, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") received the Excellence Services Label for its Customer and Technical Services in EMEA, awarded by the independent association Esprit de Service France, and in accordance with the international standard ISO 23592, a global framework for designing and delivering outstanding customer experiences. QuidelOrtho is the first medical device company to receive this …

ProShares Ultra Bitcoin ETF is a 2x leveraged bitcoin ETF facing significant downside risk amid current bearish technical patterns. BITU severely underperformed its expected 2x return, posting a -65% one-year loss vs. IBIT's -17%, due to volatility drag. Technical analysis highlights bearish flag and head-and-shoulders patterns in Bitcoin, signaling potential for further sharp declines.

The stock market hates uncertainty, and nothing creates uncertainty quite like a technological breakthrough that threatens to erase an entire industry. For shareholders of Unity Software NYSE: U, the last few trading sessions have been a lesson in emotional whiplash.

PayPal just saw a major slowdown on a metric that's closely watched by investors. Soon HP veteran Enrique Lores will be tasked with trying to turn the company around.

HP Inc on Tuesday named Bruce Broussard as the company's interim chief executive officer effective immediately.

Credo Technology is upgraded to 'Strong Buy' after a 23% share price dip despite positive earnings revisions and robust AI infrastructure tailwinds. CRDO delivered a 272% YoY revenue spike and 35% EPS beat in FQ2 2026; FQ3 guidance implies further triple-digit growth. Major AI players' aggressive 2026 CapEx and the company's Blue Heron product launch are expected to expand the addressable market and drive further earnings upgrades.

Italian energy group Eni and Q8 Italy have agreed to jointly build and operate a new biorefinery at Priolo, in Sicily, a major step in the conversion of the site's former chemical facilities, the two companies said on Tuesday.

PayPal said on Tuesday it has named Enrique Lores as president and CEO, effective March 1.

Disney shares edged higher premarket Friday ahead of the announcement of a successor for Bob Iger as CEO. The media giant reported quarterly earnings on Monday, beating Wall Street's expectations.

FREDERICK, Md., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to two new employees. On February 2, 2026, the Company issued to these employees options to purchase an aggregate of 12,050 shares of the Company's common stock with an exercise price of $6.79, the closing trading price of the Company's common stock on the Nasdaq Global Market on the date of grant. The options were granted pursuant to the Company's Amended and Restated 2018 Employment Inducement Incentive Award …

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that pivotal clinical validation data from the ACROBAT study (NCT04635384) will be presented at the 2026 Tandem Meetings, Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®,.

OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwards Li.

Pfizer also releases positive top-line results from a trial for its injectable GLP-1 receptor agonist in adults with obesity.

ST. LOUIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (the “Company”) today announced that its President and Chief Executive Officer Darcy Davenport has decided to retire from the Company, effective upon the earlier of the appointment of a new Chief Executive Officer or September 30, 2026, the end of the Company's fiscal year. Ms. Davenport will continue to serve as President and Chief Executive Officer and as a member of the Board until the effective date of the transition, after which she will serve in an advisory role to ensure a smooth transition of leadership responsibilities and …